SELLAS Life Sciences (SLS) Capital Leases (2010 - 2014)
SELLAS Life Sciences' Capital Leases was $17,000 in Q3 2014, down 43.3% from $30,000 a year earlier and down 10.5% from the prior quarter.
Powered by 
Analysis
SELLAS Life Sciences (SLS) Capital Leases (2010 - 2014) Analysis & Trends
At the end of FY2013, Capital Leases at SELLAS Life Sciences came in at $26,000, down 49.0% from FY2012.
- Capital Leases shows a three-year compound annual growth rate of 9.1% (FY2010 to FY2013).
- In earlier years, Capital Leases was $51,000 in FY2012 (+59.4%), $32,000 in FY2011 (+60.0%) and $20,000 in FY2010.
- The Q3 2014 figure marks the lowest quarterly Capital Leases since Q3 2011.
- Compared with a year earlier, Capital Leases has declined for five straight quarters, with an average decline of 18.8% over the last seven quarters.
- The best year-over-year quarter for Capital Leases over five years was Q3 2012 (growth of 264.3%); the worst was Q1 2014 (a decline of 54.9%).
- Per Business Quant data, SLS's Capital Leases in the three quarters before Q3 2014 was $19,000 (Q2 2014), $23,000 (Q1 2014) and $26,000 (Q4 2013).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | SELLAS Life Sciences | 2.32 Bn | 2.32 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2014 | 17,000.00 |
| Jun 30, 2014 | 19,000.00 |
| Mar 31, 2014 | 23,000.00 |
| Dec 31, 2013 | 26,000.00 |
| Sep 30, 2013 | 30,000.00 |
| Jun 30, 2013 | 34,000.00 |
| Mar 31, 2013 | 51,000.00 |
| Dec 31, 2012 | 51,000.00 |
| Sep 30, 2012 | 51,000.00 |
| Mar 31, 2012 | 36,000.00 |
| Dec 31, 2011 | 32,000.00 |
| Sep 30, 2011 | 14,000.00 |
| Jun 30, 2011 | 10,000.00 |
| Dec 31, 2010 | 20,000.00 |
API Access
SELLAS Life Sciences Capital Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-leases&ticker=SLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-leases", "ticker": "SLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-leases&ticker=SLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();